HNO Eidelstedt
- Address
- Eidelstedter Platz 18, 22523 Hamburg, Germany
HNO Eidelstedt - Auditory Medicine Research Center
HNO Eidelstedt is a specialized ENT research center with particular expertise in auditory disorders and hearing loss treatments. The center focuses on evaluating innovative therapeutic approaches for sudden hearing conditions, conducting clinical trials that compare novel interventions with established standard-of-care treatments.
- Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) treatment studies
- Middle ear injection therapies and localized drug delivery systems
- Comparative efficacy trials of novel versus standard steroid treatments
The research center specializes in assessing moderately-severe to profound hearing loss cases, utilizing pure tone audiometry and advanced hearing threshold measurements to evaluate treatment outcomes. HNO Eidelstedt's work contributes to advancing therapeutic options for patients experiencing sudden and unexplained hearing loss, with a focus on improving both efficacy and safety profiles of emerging treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in HNO Eidelstedt
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Intratympanic AC102 Versus Oral Prednisolone in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized, Blinded, Phase II Study | AudioCure Pharma GmbH | Phase II | Not Recruiting | Aug 2022 | Jan 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole | 1 | Unknown | 2022-08-08 | 2022-08-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.